Squarepoint
IDXG

Squarepoint’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

Squarepoint’s Portfolio IDXG Stock Details IDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-20,755
Closed -$65K – 3889
2020
Q4 		$65K Sell
20,755
-4,410
-18% -$14.5K ﹤0.01% 2779
2020
Q3 		$78K Buy
+25,165
New +$114K ﹤0.01% 2322

Other funds holding IDXG

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Squarepoint's IDXG Position: Q1 2021 in Review

Squarepoint sold out of Interpace Biosciences, Inc. Common Stock (IDXG) in Q1 2021, closing a stake of 20,755 shares — an estimated $65K sold.

Squarepoint first reported a position in IDXG in Q3 2020 and held it in 2 quarters. The position peaked at $78K in Q3 2020. 3 funds tracked by Wall St. Rank hold IDXG as of Q1 2021.

  • Squarepoint reported no remaining Interpace Biosciences, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Squarepoint sold 20,755 Interpace Biosciences, Inc. Common Stock shares in Q1 2021, an estimated $65K.
  • Squarepoint first reported a position in Interpace Biosciences, Inc. Common Stock in Q3 2020 and held it in 2 quarters.
  • Squarepoint's Interpace Biosciences, Inc. Common Stock position peaked at $78K in Q3 2020.
  • 3 funds tracked by Wall St. Rank held Interpace Biosciences, Inc. Common Stock as of Q1 2021.

Based on Squarepoint's 13F filing for Q1 2021, filed 17 May 2021.